Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

AIMS: Sodium–glucose co‐transporter 2 (SGLT2) inhibitors improve clinical outcome in patients with heart failure (HF), but the mechanisms behind their beneficial effects are not yet fully understood. We examined the effects of empagliflozin on renal sodium and glucose handling in patients with acute...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Heart Fail
Main Authors: Boorsma, Eva M., Beusekamp, Joost C., ter Maaten, Jozine M., Figarska, Sylwia M., Danser, A.H. Jan, van Veldhuisen, Dirk J., van der Meer, Peter, Heerspink, Hiddo J.L., Damman, Kevin, Voors, Adriaan A.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd. 2020
Assuntos:
Acute Heart Failure
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048437/
https://ncbi.nlm.nih.gov/pubmed/33251643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2066
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares